Large-Scale and Local Functional Connectivity Changes following Psilocybin Administration in Methamphetamine Use

Joga Chaganti1, Krista J Siefried2,3,4, Veda S Vyakaranam5

  • 1From the Thomas Jefferson University (J.C.), Philadelphia, Pennsylvania joga.chaganti@jefferson.edu.

Abstract

Insights

Psilocybin treatment, combined with psychotherapy, reorganized brain networks in individuals with methamphetamine use disorder. This intervention improved functional connectivity and was linked to reduced drug use and psychological distress.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Addiction Research

Background:

  • Methamphetamine (MA) use disorder disrupts brain networks crucial for cognitive control, attention, and salience.
  • Resting-state functional MRI (rs-fMRI) can identify these disruptions, but network recovery after treatment is understudied.

Purpose of the Study:

  • To investigate changes in large-scale and local functional connectivity after psilocybin administration in individuals with MA use disorder.

Main Methods:

  • Prospective longitudinal study using rs-fMRI before and after psilocybin and psychotherapy.
  • Assessed large-scale connectivity in default mode, salience, dorsal attention, and executive control networks.
  • Evaluated local connectivity using regional homogeneity (ReHo) and correlated changes with clinical outcomes.

Main Results:

  • Psilocybin administration led to significant reorganization within and between attentional, default mode, and salience networks.
  • Increased network integration correlated with increased ReHo in frontal and sensorimotor regions.
  • Reduced MA use linked to restored frontostriatal and attentional connectivity; reduced distress linked to strengthened attentional and prefrontal-striatal circuits.

Conclusions:

  • Psilocybin administration induced measurable reorganization of brain connectivity and local coherence in MA use disorder.
  • Findings suggest psilocybin may promote network plasticity, offering potential as an imaging biomarker for stimulant addiction treatment.

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
1.0K
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
1.1K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K